Literature DB >> 9228223

Stress and alopecia areata: a psychodermatologic study.

M A Gupta1, A K Gupta, G N Watteel.   

Abstract

Psychosocial stress has been reported to play a role in the onset and/or exacerbation of alopecia areata. Little is known about the clinical characteristics of alopecia areata patients whose alopecia is stress-reactive. We examined the relation between the stress reactivity of alopecia areata and a wide range of psychosocial measures among 16 patients with alopecia areata/totalis and 28 patients with alopecia universalis. The degree to which the alopecia was exacerbated by stress was measured by patient ratings on a 10-point scale. A wide range of psychologic measures correlated (p<0.05) with the stress reactivity score. Stepwise logistic regression analysis revealed that patients with higher depression scores were more likely to be in the high-stress reactor group. Patients whose alopecia is stress-reactive may suffer from depressive illness, a potentially important consideration in the overall management of such patients.

Entities:  

Mesh:

Year:  1997        PMID: 9228223     DOI: 10.2340/0001555577296298

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  19 in total

Review 1.  [Alopecia areata. Clinical aspects, pathogenesis and rational therapy of a T-cell-induced autoimmune disease].

Authors:  P Freyschmidt-Paul; R Happle; R Hoffmann
Journal:  Hautarzt       Date:  2003-08       Impact factor: 0.751

2.  CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata.

Authors:  Zhenpeng Dai; Luzhou Xing; Jane Cerise; Eddy Hsi Chun Wang; Ali Jabbari; Annemieke de Jong; Lynn Petukhova; Angela M Christiano; Raphael Clynes
Journal:  J Immunol       Date:  2016-07-13       Impact factor: 5.422

3.  Topical diphenylcyclopropenone plus topical 0.5% anthralin versus topical diphenylcyclopropenone alone for the treatment of chronic extensive alopecia areata: A split-scalp, double-blind, controlled study.

Authors:  Rattapon Thuangtong; Saroj Suvansuthi; Pitchaya Maneeprasopchoke; Thanisorn Sukakul; Rattiya Techakajornkeart; Pichanee Chaweekulrat; Supisara Wongdama; Daranporn Triwongwaranat
Journal:  Int J Trichology       Date:  2022-05-24

4.  Alopecia Areata as a Proximal Risk Factor for the Development of Comorbid Depression: A Population-based Study.

Authors:  Dana Tzur Bitan; Daniella Berzin; Khalaf Kridin; Yaron Sela; Arnon Cohen
Journal:  Acta Derm Venereol       Date:  2022-03-14       Impact factor: 3.875

5.  Surgical methods for full-thickness skin grafts to induce alopecia areata in C3H/HeJ mice.

Authors:  Kathleen A Silva; John P Sundberg
Journal:  Comp Med       Date:  2013-10       Impact factor: 0.982

6.  Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model.

Authors:  Xingqi Zhang; Mei Yu; Wayne Yu; Joanne Weinberg; Jerry Shapiro; Kevin J McElwee
Journal:  J Invest Dermatol       Date:  2008-11-20       Impact factor: 8.551

7.  Probing the effects of stress mediators on the human hair follicle: substance P holds central position.

Authors:  Eva M J Peters; Sofia Liotiri; Eniko Bodó; Evelin Hagen; Tamás Bíró; Petra C Arck; Ralf Paus
Journal:  Am J Pathol       Date:  2007-11-30       Impact factor: 4.307

8.  The association between alopecia areata and anxiety, depression, schizophrenia, and bipolar disorder: a population-based study.

Authors:  Dana Tzur Bitan; Daniella Berzin; Khalaf Kridin; Arnon Cohen
Journal:  Arch Dermatol Res       Date:  2021-06-05       Impact factor: 3.017

9.  Psychological interventions in the management of common skin conditions.

Authors:  Philip D Shenefelt
Journal:  Psychol Res Behav Manag       Date:  2010-03-26

10.  Efficacy of korean red ginseng in the treatment of alopecia areata.

Authors:  Ga Na Oh; Sang Wook Son
Journal:  J Ginseng Res       Date:  2012-10       Impact factor: 6.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.